Mail

Australia markets open in 6 hours 47 minutes

ALL ORDS
7,219.40
+75.60(+1.06%)
AUD/USD
0.6706
+0.0055(+0.82%)
ASX 200
7,034.10
+72.10(+1.04%)
OIL
73.76
+0.95(+1.30%)
GOLD
1,968.20
+14.40(+0.74%)
Bitcoin AUD
40,169.12
-357.20(-0.88%)

Get our best money-saving hacks and pro tips now

Exopharm Limited (EX1.AX)

ASX - ASX Delayed price. Currency in AUD

Add to watchlist

0.0140

+0.0010

(+7.69%)

At close: 03:17PM AEDT

Currency in AUD

Valuation measures⁴

Market cap (intra-day)	2.36M
Enterprise value	1.69M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	N/A
Price/book (mrq)	0.54
Enterprise value/revenue	16.92
Enterprise value/EBITDA	-0.25

Trading information

Stock price history

Beta (5Y monthly)	1.21
52-week change ³	-94.95%
S&P500 52-week change ³	-14.12%
52-week high ³	0.3000
52-week low ³	0.0097
50-day moving average ³	0.0333
200-day moving average ³	0.0979

Share statistics

Avg vol (3-month) ³	933.16k
Avg vol (10-day) ³	998.09k
Shares outstanding ⁵	177.72M
Implied shares outstanding ⁶	N/A
Float ⁸	100.63M
% held by insiders ¹	47.62%
% held by institutions ¹	0.00%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	30 June 2022
Most-recent quarter (mrq)	31 Dec 2022

Profitability

Profit margin	-108.25%
Operating margin (ttm)	-104.77%

Management effectiveness

Return on assets (ttm)	-38.52%
Return on equity (ttm)	-88.24%

Income statement

Revenue (ttm)	6.4M
Revenue per share (ttm)	0.04
Quarterly revenue growth (yoy)	4,356.50%
Gross profit (ttm)	15.63k
EBITDA	-5.41M
Net income avi to common (ttm)	-6.93M
Diluted EPS (ttm)	-0.0400
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	1.68M
Total cash per share (mrq)	0.01
Total debt (mrq)	1.59M
Total debt/equity (mrq)	36.19
Current ratio (mrq)	1.62
Book value per share (mrq)	0.03

Cash flow statement

Operating cash flow (ttm)	-6.98M
Levered free cash flow (ttm)	-5.85M